Inhibition of plating of human T cell leukemia virus type I and syncytium-inducing types of human immunodeficiency virus type I by polycations

AIDS Research and Human Retroviruses

Volumn 13, Issue 17, 1997, Pages 1517-1523

  Haraguchi, Yuji ^a   Takeuchi, Yasuhiro ^a,b   Hoshino, Hiroo ^a  

^a GUNMA UNIVERSITY   (Japan)

^b INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DIETHYLAMINOETHYLDEXTRAN; HEXADIMETHRINE BROMIDE; VIRUS ANTIGEN;

ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS 1; NONHUMAN; PRIORITY JOURNAL; SYNCYTIUM; VESICULAR STOMATITIS VIRUS; VIRUS CULTURE; VIRUS ENVELOPE; VIRUS INHIBITION;

EID: 0030727556     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.1997.13.1517     Document Type: Article

References (50)

1. Dug-Nguyen H: Enhancing effect of DEAE-dextran on the focus-forming titer of murine sarcoma virus (Harvey strain). J Virol 1968;2:643-644.
2. Forrester JA and Salaman MH: Cell electrophoretic mobilities in Friend virus disease. Nature (London) 1967;215:279-280.
3. Hesse J, Ebbesen P, and Kristensen G: Correlation between polyion effect on cell susceptibility to in vitro infection with murine C-type viruses and polyion effect on some membrane-related functions. Intervirology 1984;9:173-183.
4. Somers KD and Kirsten WH: FOCUS formation by murine sarcoma virus: Enhancement by DEAE-dextran. Virology 1968;36: 155-157.
5. Toyoshima K and Vogt PK: Enhancement and inhibition of avian sarcoma viruses by polycations and polyanions. Virology 1969; 38:1563-1566.
6. Clapham PR, Nagy K, and Weiss RA: Pseudotype of human T-cell leukemia virus type 1 and 2: Neutralization by patients' sera. Proc Natl Acad Sci USA 1984;81:2886-2889.
7. Hoshino H, Shimoyama M, Miwa M, and Sugimura T: Detection of lymphocytes producing a human retrovirus associated with adult T-cell leukemia by syncytia induction assay. Proc Natl Acad Sci USA 1983;80:7337-7341.
8. Hoshino H, Clapham PR, Weiss RA, Miyoshi I, Yoshida M, and Miwa M: Human T-cell leukemia virus type 1: Pseudotype neutralization of Japanese and American isolates with human and rabbit sera. Int J Cancer 1985;36:671-675.
9. Nagy K, Clapham P, Cheingsong-Popov R, and Weiss RA: Human T-cell leukemia virus type 1: Induction by syncytia and inhibition by patients' sera. Int J Cancer 1983;32:321-328.
10. Haraguchi Y, Yang D, Handa A, Shimizu N, Tanaka Y, and Hoshino H: Detection of neutralizing antibodies against human T-cell leukemia virus type 1 using a cell-free infection system and polymerase chain reaction. Int J Cancer 1994;59:416-421.
11. Yang D, Yaraguchi Y, Iwai H, Handa A, Shimizu N, and Hoshino H: Inhibition of adsorption of human T-cell-leukemia virus type 1 by a plant lectin, wheat-germ agglutinin. Int J Cancer 1994;56: 100-105.
12. Kikukawa R, Koyanagi Y, Harada S, Kobayashi N, Hatanaka M, and Yamamoto N: Differential susceptibility to the acquired immunodeficiency syndrome retrovirus in cloned cells of human leukemic T-cell line Molt-4. J Virol 1986;57:1159-1162.
13. Miyoshi I, Kubonishi I, Yoshimoto S, Akagi T, Ohtuki Y, Shiraishi Y, Nagata K, and Hinuma Y: Type C virus particles in a cord T-cell line derived by co-cultivating normal human cord leukocytes and human leukemic T-cells. Nature (London) 1981;294:770-771.
14. Salahuddin SZ, Markham PD, Wong-Staal F, Franchini O, Kalyanaraman VS, and Gallo RC: Restricted expression of human T-cell leukemia-lymphoma virus (HTLV) in transformed human umbilical cord blood lymphocytes. Virology 1983;129:51-54.
15. Popovic M, Sarin PS, Pobert-Guroff M, Kalyanaman VS, Mann D, Minowada J, and Gallo RC: Isolation and transmission of human retrovirus (Human T-cell leukemia virus). Science 1983;219: 856-859.
16. Hoshino H, Esumi H, Miwa M, Shimoyama M, Minato K, Tobinai K, Hirose M, Watanabe S, Inada N, Kinoshita K, Kamihira S, Ichimaru M, and Sugimura T: Establishment and characterization of 10 cell lines derived from patients with adult T-cell leukemia. Proc Natl Acad Sci USA 1983;80:6061-6065.
17. Hoshino H, Nakamura T, Tanaka Y, Miyoshi I, and Yanagihara R: Functional conservation of the neutralizing domains on the external envelope glycoprotein of cosmopolitan and Melanesian strains of human T cell leukemia/lymphoma virus type 1. J Infect Dis 1993;168:1368-1373.
18. McAllister RM, Gardner MB, Greene AE, Bradt C, Nichols WW, and Landing BH: Cultivation in vitro of cells derived from a human osteosarcoma. Cancer 1971;27:397-402.
19. Yanagihara R, Nerurkar VR, Garruto RM, Miller MA, Leon-Monzon ME, Jenkins CL, Sanders RC, Liberski PP, Alpers MP, and Gajdusek DC: Characterization of a variant of human T-lymphotropic virus type I isolated from a healthy member of a remote, recently contacted group in Papua New Guinea. Proc Natl Acad Sci USA 1991;88:1446-1450.
20. Bigner DD, Bigner SH, Ponten J, Westermark B, Mahley MS, Ruoslahti E, Hershman H, Eng LF, and Wikstrand CJ: Heterogeneity of genotypic and phenotypic characteristics of fifteen permanent cell lines derived from human gliomas. J Neuropathol Exp Neurol 1981;40:201-229.
21. Westermark B, Ponten J, and Huggosson R: Determinant for the establishment of permanent tissue culture line human gliomas. Acta Pathol Microbiol Scand 1973;81:791-805.
22. Clapham PR, Blanc D, and Weiss RA: Specific cell surface requirements for the infection of CD4-positive cells by human immunodeficiency virus type 1 and 2 and by simian immunodeficiency virus. Virology 1991;181:703-715.
23. Takeuchi Y, Akutsu M, Murayama K, Shimizu N, and Hoshino H: Host range mutant of human immunodeficiency virus type 1: Modification of cell tropism by a single point mutation at the neutralization epitope in the env gene. J Virol 1991;65:1710-1718.
24. McKnight A, Weiss RA, Shotton C, Takeuchi Y, Hoshino H, and Clapham PR: Change in tropism upon immune escape by human immunodeficiency virus. J Virol 1995;69:3167-3170.
25. Takeuchi Y, Francois-Loi CC, Lachmann PJ, Okada H, Weiss RA, and Collins MKL: Type C retrovirus inactivation by human complement is determined by both the viral genome and the producer cell. J Virol 1994;68:8001-8007.
26. Takeuchi Y, Simpson G, Vile RG, Weiss RA, and Collins MKL: Retroviral pseudotypes produced by rescue of a Moloney murine leukemia virus vector by C-type, but not D-type, retroviruses. Virology 1992;186:792-794.
27. Takeuchi Y, Inagaki M, Kobayashi N, and Hoshino H: Isolation of human immunodeficiency virus from a Japanese hemophilia B patient with AIDS. Jpn J Cancer Res 1987;78:11-15.
28. Shimizu SN, Shimizu GN, Takeuchi Y, and Hoshino H: Isolation and characterization of human immunodeficiency virus type 1 variants infectious to brain-derived cells: Detection of common point mutations in the V3 region of the env gene of variants. J Virol 1994;68:6130-6135.
29. Popovic M, Sarngadharan MG, Read E, and Gallo RC: Detection, isolation, and continuous production of cytopathic retroviruses (HTLV-III) from patients with AIDS and pre-AIDS. Science 1984;224:497-500.
30. Cheng-Mayer C and Levy JA: Distinct biological and serological properties of human immunodeficiency viruses from the brain. Ann Neurol 1988;23:58-61.
31. Gartner S, Markovitis P, Markovitz DM, Kaplan MH, Gallo RC, and Popovic M: The role of mononuclear phagocytes in HTLV-III/LAV infection. Science 1986;233:215-219.
32. Tailor CS, Takeuchi Y, O'Hara B, Johann SV, Weiss RA, and Collins MKL: Mutation of amino acids within the gibbon ape leukemia virus (GALV) receptor differentially affects feline leukemia virus subgroup B, simian sarcoma-associated virus, and GALV infection. J Virol 1993;67:6737-6741.
33. Handa A, Hoshino H, Nakajima K, Adachi M, Ikeda K, Achiwa K, Itoh T, and Suzuki Y: Inhibition of infection with human immunodeficiency virus type 1 by sulfated gangliosides. Biochem Biophys Res Commun 1991;175:1-9.
34. Bailey CA, Miller DK, and Lenard J: Effects of DEAE-dextran on infection and hemolysis by VSV. Evidence that nonspecific electrostatic interactions mediate effective binding of VSV to cells. Virology 1984;133:111-118.
35. Krichbaum-Stenger K, Poiesz BJ, Keller P, Ehrich G, Gawalchin J, Davis BH, and Moore JL: Specific adsorption of HTLV-1 to various target human and animal cells. Blood 1987;70:1303-1311.
36. Sommerfelt MA and Weiss RA: Receptor interference groups of 20 retroviruses plating on human cells. Virology 1990;176:58-69.
37. Seiki M, Hattori S, Hirayama Y, and Yoshida M: Human adult T-cell leukemia virus: Complete nucleotide sequence of the provirus genome integrated in leukemia cell DNA. Proc Natl Acad Sci USA 1983;80:3618-3622.
38. Shimotohno K, Takahashi Y, Shimizu N, Gojobori T, Golde DW, Chen ISY, Miwa M, and Sugimura T: Complete nucleotide sequence of an infectious clone of human T-cell leukemia virus type II: An open reading fram for the protease gene. Proc Natl Acad Sci USA 1985;82:3101-3105.
39. Chesebro B and Wehrly K: Development of a sensitive quantitative focal assay for human immunodeficiency virus infectivity. J Virol 1988;60:3779-3788.
40. Hwang SS, Boyle TJ, Lyerly HK, and Cullen BR: Identification of the envelope V3 loop as the primary determinant of cell tropism in HIV-1. Science 1991;253:71-74.
41. O'Brien WA, Koyanagi Y, Namazie A, Zhao J-Q, Diagne A, Idler K, Zack JA, and Chen ISY: HIV-1 tropism for mononuclear phagocytes can be determined by regions of gp120 outside the CD4-binding domain. Nature (London) 1990;348:69-73.
42. Shioda T, Levy JA, and Cheng MC: Small amino acid changes in the V3 hypervariable region of gp120 can affect the T-cell-line and macrophage tropism of human immunodeficiency virus type 1. Proc Natl Acad Sci USA 1992;89:9434-9438.
43. Fouchier RAM, Groenink M, Kootstra NA, Termette M, Huisman HG, Miedema F, and Schuitemaker H: Phenotype-associated sequence variation in the third variable domain of the human immunodeficiency virus type 1 gp120 molecule. J Virol 1992;66: 3183-3187.
44. Deng H, Liu R, Ellmeier W, Choe S, Unutmaz D, Burkhart M, Marzio PD, Marmon S, Sutton RE, Hill CM, Davis CB, Peiper SC, Schall TJ, Littman DR, and Landau NR: Identification of a major co-receptor for primary isolates of HIV-1. Nature (London) 1996;381:661-666.
45. + cells is mediated by the chemokine receptor CC-CKR-5. Nature (London) 1996;381:667-673.
46. Feng Y, Broder CC, Kennedy PE, and Berger EA: HIV-1 entry cofactor: Functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science 1996;272:872-877.
47. Loetsher M, Geiser T, O'Reilly T, Zwahlen R, Baggiolini M, and Moser B: Cloning of a human seven-transmembrane domain receptor, LESTR, that is highly expressed in leukocytes. J Biol Chem 1994;269:232-237.
48. Samson M, Labbe O, Mollereau C, Vassart G, and Parmentier M: Molecular cloning and functional expression of new human CC-chemokine receptor gene. Biochemistry 1996;35:3362-3367.
49. Rucher J, Samson M, Doranz BJ, Libert F, Berson JF, Yi Y, Smyth RJ, Collman RG, Broder CC, Vassart G, Doms RW, and Parmentier M: Regions in β-chemokine receptors CCR5 and CCR2b that determine HIV-1 cofactor specificity. Cell 1996;87:437-446.
50. Castro BA, Weiss CD, Wiviott LD, and Levy JA: Optimal conditions for recovery of the human immunodeficiency virus from peripheral blood mononuclear cells. J Clin Microbiol 1988;26: 2371-2376.